Literature DB >> 19573558

TWEAK stimulation of kidney resident cells in the pathogenesis of graft versus host induced lupus nephritis.

Alberto Molano1, Payal Lakhani, Adi Aran, Linda C Burkly, Jennifer S Michaelson, Chaim Putterman.   

Abstract

The cytokine TWEAK demonstrates potent kidney proinflammatory and proliferative effects. Recently, we have shown that interactions of TWEAK with its receptor Fn14 are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host (cGVH) induced model of lupus. Fn14 is expressed by macrophages and resident kidney cells; we hypothesized that TWEAK binding to both cell types contributes to the pathogenesis of lupus nephritis. To address this question, we generated bone marrow chimaeras and compared the progression of nephritis during cGVH induced lupus in mice expressing Fn14 only on bone marrow-derived cells, versus mice displaying Fn14 only on non-bone marrow-derived cells. While Fn14 deficiency did not significantly affect autoantibody titers, Fn14 deficiency on bone marrow-derived cells did not inhibit nephritis initiation in mice with Fn14 sufficient non-hematopoeitic cells. Conversely, expression of Fn14 only on bone marrow-derived cells resulted in a delayed, milder disease course. To further explore the role of macrophages, we depleted macrophages during cGVH induction. Surprisingly, we found that macrophage depleted mice displayed significantly increased titers of anti-DNA antibodies and worse kidney disease. We conclude that the presence of Fn14 on resident kidney cells alone may be sufficient to initiate nephritis in this murine model of lupus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19573558     DOI: 10.1016/j.imlet.2009.06.010

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  19 in total

1.  Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) mediates p38 mitogen-activated protein kinase activation and signal transduction in peripheral blood mononuclear cells from patients with lupus nephritis.

Authors:  Liu Zhi-Chun; Zhou Qiao-Ling; Liu Zhi-Qin; Li Xiao-Zhao; Zuo Xiao-xia; Tang Rong
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

Review 2.  TWEAK as a target for therapy in systemic lupus erythematosus.

Authors:  Rui-Xue Leng; Hai-Feng Pan; Wei-Zi Qin; Chao Wang; Li-Li Chen; Jin-Hui Tao; Dong-Qing Ye
Journal:  Mol Biol Rep       Date:  2010-04-01       Impact factor: 2.316

Review 3.  Lupus nephritis: the evolving role of novel therapeutics.

Authors:  Brad H Rovin; Samir V Parikh
Journal:  Am J Kidney Dis       Date:  2014-01-07       Impact factor: 8.860

4.  Biomeasures and mechanistic modeling highlight PK/PD risks for a monoclonal antibody targeting Fn14 in kidney disease.

Authors:  Xiaoying Chen; Vahid Farrokhi; Pratap Singh; Mireia Fernandez Ocana; Jenil Patel; Lih-Ling Lin; Hendrik Neubert; Joanne Brodfuehrer
Journal:  MAbs       Date:  2017-11-30       Impact factor: 5.857

Review 5.  Tumor necrosis factor-like weak inducer of apoptosis and its potential roles in lupus nephritis.

Authors:  Zhi-Chun Liu; Qiao-Ling Zhou
Journal:  Inflamm Res       Date:  2012-04       Impact factor: 4.575

6.  Deficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis.

Authors:  Yumin Xia; Leal C Herlitz; Simona Gindea; Jing Wen; Rahul D Pawar; Alexander Misharin; Harris Perlman; Lan Wu; Ping Wu; Jennifer S Michaelson; Linda C Burkly; Chaim Putterman
Journal:  J Am Soc Nephrol       Date:  2014-09-30       Impact factor: 10.121

7.  TWEAK-Fn14 as a mediator of acute kidney injury.

Authors:  Joel M Weinberg
Journal:  Kidney Int       Date:  2011-01       Impact factor: 10.612

8.  Fn14 deficiency protects lupus-prone mice from histological lupus erythematosus-like skin inflammation induced by ultraviolet light.

Authors:  Jessica Doerner; Samantha A Chalmers; Adam Friedman; Chaim Putterman
Journal:  Exp Dermatol       Date:  2016-12       Impact factor: 3.960

Review 9.  TNF superfamily: a growing saga of kidney injury modulators.

Authors:  Maria D Sanchez-Niño; Alberto Benito-Martin; Sara Gonçalves; Ana B Sanz; Alvaro C Ucero; Maria C Izquierdo; Adrian M Ramos; Sergio Berzal; Rafael Selgas; Marta Ruiz-Ortega; Jesus Egido; Alberto Ortiz
Journal:  Mediators Inflamm       Date:  2010-10-04       Impact factor: 4.711

10.  Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis.

Authors:  Yumin Xia; Sean R Campbell; Anna Broder; Leal Herlitz; Maria Abadi; Ping Wu; Jennifer S Michaelson; Linda C Burkly; Chaim Putterman
Journal:  Clin Immunol       Date:  2012-08-20       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.